Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-21-070467

Chief Executive Officer sold 60,000 shares at an average $67.56 ($4,053,431)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Anzalone Christopher Richard Chief Executive Officer 2021-12-15 Sale −25,857 $66.28 $1,713,802 3,253,165 D
Anzalone Christopher Richard Chief Executive Officer 2021-12-15 Sale −14,857 $67.19 $998,242 3,238,308 D
Anzalone Christopher Richard Chief Executive Officer 2021-12-15 Sale −3,074 $68.20 $209,647 3,235,234 D
Anzalone Christopher Richard Chief Executive Officer 2021-12-15 Sale −9,223 $69.52 $641,183 3,226,011 D
Anzalone Christopher Richard Chief Executive Officer 2021-12-15 Sale −6,989 $70.19 $490,558 3,219,022 D
Open-market sales · 60,000 sh · avg $67.56 · $4,053,431
Loading xslF345X03/doc4.xml…